Akebia Therapeutics, Inc. (50) | Human Resources (13)

Browse by Subcategory

Recent Contracts

Form of Officer Retention Letter Agreement (Filed With SEC on May 9, 2022)
Separation Agreement with Dell Faulkingham, dated May 5, 2022 (Filed With SEC on May 9, 2022)
Amended and Restated Cash Incentive Plan, effective January 19, 2022 (Filed With SEC on March 1, 2022)
Non-Employee Director Compensation Program, effective January (Filed With SEC on February 25, 2021)
Consulting Agreement (Filed With SEC on November 5, 2020)
Form of Employee Agreement (Confidentiality, Non-Competition, Non-Solicitation and Development Agreement) applicable to officers (Filed With SEC on March 26, 2019)
Form of Retention and Separation Agreement for Michel Dahan and Nicole R. Hadas (Filed With SEC on May 9, 2022)
Form of Officer Performance-Based Stock Option Award, under the Company's 2014 Incentive Plan, as amended (Filed With SEC on November 4, 2021)
Form of Officer Performance-Based Restricted Stock Unit Award, under the Company's 2014 Incentive Plan, as amended (Filed With SEC on November 4, 2021)
Form of Officer Cash Bonus Letter Agreement (Filed With SEC on November 4, 2021)
Master Consulting Services Agreement, dated as of June 10, 2019, by and between Akebia Therapeutics, Inc. and Scott A. Canute (Filed With SEC on August 8, 2019)
Form of Officer Restricted Stock Unit Award Agreement under 2014 Incentive Plan (Filed With SEC on March 26, 2019)
Amended and Restated Non-Employee Director Compensation Program, effective January 30, 2019 (Filed With SEC on March 26, 2019)